Sachs J, Malaney P: The economic and social burden of malaria. Nature. 2002, 415: 680-685. 10.1038/415680a.
Article
CAS
PubMed
Google Scholar
Gething PW, Elyazar IRF, Moyes CM, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HFL, Price RN, Mueller I, Baird JK, Hay SI: A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis. 2012, 6: e1814-10.1371/journal.pntd.0001814.
Article
PubMed Central
PubMed
Google Scholar
Battle KE, Gething PW, Elyazar IR, Moyes CL, Sinka ME, Howes RE, Guerra CA, Price RN, Baird KJ, Hay SI: The global public health significance of Plasmodium vivax. Adv Parasitol. 2012, 80: 1-111.
Article
PubMed
Google Scholar
Anstey NM, Russell B, Yeo TW, Price RN: The pathophysiology of vivax malaria. Trends Parasitol. 2009, 25: 220-227. 10.1016/j.pt.2009.02.003.
Article
CAS
PubMed
Google Scholar
Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti , Elyazar I, Bangs MJ, Maguire JD, Baird JK: Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg. 2007, 77: 984-991.
PubMed
Google Scholar
Karyana M, Burdarm L, Yeung S, Kenangalem E, Wariker N, Maristela R, Umana KG, Vemuri R, Okoseray MJ, Penttinen PM, Ebsworth P, Sugiarto P, Anstey NM, Tjitra E, Price RN: Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J. 2008, 7: 148-10.1186/1475-2875-7-148.
Article
PubMed Central
PubMed
Google Scholar
Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A: Plasmodium vivax malaria. Emerg Infect Dis. 2005, 11: 132-134. 10.3201/eid1101.040519.
Article
PubMed Central
PubMed
Google Scholar
Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM: Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007, 77: 79-87.
PubMed Central
PubMed
Google Scholar
Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN: Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008, 5: e128-10.1371/journal.pmed.0050128.
Article
PubMed Central
PubMed
Google Scholar
Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, Muller I: Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008, 5: e127-10.1371/journal.pmed.0050127.
Article
PubMed Central
PubMed
Google Scholar
Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Hasanuddin A, Warikar N, Sugiarto P, Tjitra E, Anstey NM, Price RN: Vivax malaria: a major cause of morbidity in early infancy. Clin Infect Dis. 2009, 48: 1704-1712. 10.1086/599041.
Article
PubMed Central
PubMed
Google Scholar
Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, McGready R, Sugiarto P, Tjitra E, Anstey NM, Price RN: Adverse pregnancy outcomes in an area where multidrug-resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis. 2008, 46: 1374-1381. 10.1086/586743.
Article
PubMed Central
PubMed
Google Scholar
Baird JK: Eliminating malaria - all of them. Lancet. 2010, 376: 1883-1885. 10.1016/S0140-6736(10)61494-8.
Article
PubMed
Google Scholar
Bockarie MJ, Dagoro H: Are insecticide-treated bednets more protective against Plasmodium falciparum than Plasmodium vivax-infected mosquitoes?. Malar J. 2006, 5: 15-10.1186/1475-2875-5-15.
Article
PubMed Central
PubMed
Google Scholar
Bousema T, Drakeley C: Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011, 24: 377-410. 10.1128/CMR.00051-10.
Article
PubMed Central
PubMed
Google Scholar
Luxemburger C, Perea WA, Delmas G, Pruja C, Pecoul B, Moren A: Permethrin-impregnated bed nets for the prevention of malaria in schoolchildren on the Thai-Burmese border. Trans R Soc Trop Med Hyg. 1994, 88: 155-159. 10.1016/0035-9203(94)90273-9.
Article
CAS
PubMed
Google Scholar
Mendis K, Sina BJ, Marchesini P, Carter R: The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001, 64: 97-106.
CAS
PubMed
Google Scholar
Sattabongkot J, Tsuboi T, Zollner GE, Sirichaisinthop J, Cui L: Plasmodium vivax transmission: chances for control?. Trends Parasitol. 2004, 20: 192-198. 10.1016/j.pt.2004.02.001.
Article
PubMed
Google Scholar
Wells TN, Burrows JN, Baird JK: Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol. 2010, 26: 145-151. 10.1016/j.pt.2009.12.005.
Article
PubMed
Google Scholar
Pampana E: A textbook of malaria eradication. 1969, London: Oxford University Press
Google Scholar
Tatem AJ, Smith DL, Gething PW, Kabaria CW, Snow RW, Hay SI: Ranking of elimination feasibility between malaria-endemic countries. Lancet. 2010, 376: 1579-1591. 10.1016/S0140-6736(10)61301-3.
Article
PubMed Central
PubMed
Google Scholar
McKenzie FE, Jeffery GM, Collins WE: Plasmodium vivax blood-stage dynamics. J Parasitol. 2002, 88: 521-535. 10.1645/0022-3395(2002)088[0521:PVBSD]2.0.CO;2.
Article
PubMed Central
PubMed
Google Scholar
Awab GR, Pukrittayakamee S, Imwong M, Dondorp AM, Woodrow CJ, Lee SJ, Day NP, Singhasivanon P, White NJ, Kaker F: Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial. Malar J. 2010, 9: 105-10.1186/1475-2875-9-105.
Article
PubMed Central
PubMed
Google Scholar
Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN: Artemisinin combination therapy for vivax malaria. Lancet Infect Dis. 2010, 10: 405-416. 10.1016/S1473-3099(10)70079-7.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN: Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet. 2007, 369: 757-765. 10.1016/S0140-6736(07)60160-3.
Article
PubMed Central
CAS
PubMed
Google Scholar
Boyd MF, Kitchen SF: On the infectiousness of patients infected with Plasmodium vivax and Plasmodium falciparum. Am J Trop Med Hyg. 1937, s1-17: 253-262.
Google Scholar
Collins WE, Sullivan JS, Nace D, Williams T, Sullivan JJ, Galland GG, Grady KK, Bounngaseng A: Experimental infection of Anopheles farauti with different species of Plasmodium. J Parasitol. 2002, 88: 295-298. 10.1645/0022-3395(2002)088[0295:EIOAFW]2.0.CO;2.
Article
PubMed
Google Scholar
Gething PW, Van Boeckel TP, Smith DL, Guerra CA, Patil AP, Snow RW, Hay SI: Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax. Parasit Vectors. 2011, 4: 92-10.1186/1756-3305-4-92.
Article
PubMed Central
PubMed
Google Scholar
Coatney GR: Relapse in malaria - an enigma. J Parasitol. 1976, 62: 3-9.
Article
CAS
PubMed
Google Scholar
Garnham PC: Malaria parasites of man: life-cycles and morphology (excluding ultrastructure). Malaria: Principles and practice of malariology. 1989, Edinburgh, UK: Churchill Livingstone, 61-96.
Google Scholar
Krotoski WA: The hypnozoite and malarial relapse. Prog Clin Parasitol. 1989, 1: 1-19.
CAS
PubMed
Google Scholar
Baird JK, Hoffman SL: Primaquine therapy for malaria. Clin Infect Dis. 2004, 39: 1336-1345. 10.1086/424663.
Article
CAS
PubMed
Google Scholar
Galappaththy GN, Omari AA, Tharyan P: Primaquine for preventing relapses in people with Plasmodium vivax malaria. Cochrane Database Syst Rev. 2007, 1: CD004389-
PubMed
Google Scholar
Anthony MP, Burrows JN, Duparc S, Moehrle JJ, Wells TN: The global pipeline of new medicines for the control and elimination of malaria. Malar J. 2012, 11: 316-10.1186/1475-2875-11-316.
Article
PubMed Central
PubMed
Google Scholar
Beutler E: G6PD deficiency. Blood. 1994, 84: 3613-3636.
CAS
PubMed
Google Scholar
Cappellini MD, Fiorelli G: Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008, 371: 64-74. 10.1016/S0140-6736(08)60073-2.
Article
CAS
PubMed
Google Scholar
WHO: Guidlines for the treatment of malaria, Second Edition. 2010, Geneva, Switzerland: World Health Organization
Google Scholar
Hay SI, Okiro EA, Gething PW, Patil AP, Tatem AJ, Guerra CA, Snow RW: Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med. 2010, 7: e1000290-10.1371/journal.pmed.1000290.
Article
PubMed Central
PubMed
Google Scholar
Patil AP, Okiro EA, Gething PW, Guerra CA, Sharma SK, Snow RW, Hay SI: Defining the relationship between Plasmodium falciparum parasite rate and clinical disease: statistical models for disease burden estimation. Malar J. 2009, 8: 186-10.1186/1475-2875-8-186.
Article
PubMed Central
PubMed
Google Scholar
Coatney GR, Cooper WC: Recrudescence and relapse in vivax malaria. Proceedings of the 4th International Congress on Tropical Medicine. 1948, 1: 629-639.
Google Scholar
Garnham PC, Bray RS, Bruce-Chwatt LJ, Draper CC, Killick-Kendrick R, Sergiev PG, Tiburskaja NA, Shute PG, Maryon M: A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics. Bull World Health Organ. 1975, 52: 21-32.
PubMed Central
CAS
PubMed
Google Scholar
Winckel CWF: Long latency in Plasmodium vivax infections in a temperate zone. Doc Med Geog Trop. 1955, 7: 292-298.
CAS
Google Scholar
Coatney GR, Collins WE, Contacos PG:Plasmodium vivax. The Primate Malarias. 1971, Bethesda, MD: U.S. National Institute of Allergy and Infectious Diseases, 43-67.
Google Scholar
Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, Del Portillo HA: Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009, 9: 555-566. 10.1016/S1473-3099(09)70177-X.
Article
CAS
PubMed
Google Scholar
Baird JK, Rieckmann KH: Can primaquine therapy for vivax malaria be improved?. Trends Parasitol. 2003, 19: 115-120. 10.1016/S1471-4922(03)00005-9.
Article
CAS
PubMed
Google Scholar
Shute PG, Lupascu G, Branzei P, Maryon M, Constantinescu P, Bruce-Chwatt LJ, Draper CC, Killick-Kendrick R, Garnham PC: A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the length of the prepatent period. Trans R Soc Trop Med Hyg. 1976, 70: 474-481. 10.1016/0035-9203(76)90132-2.
Article
CAS
PubMed
Google Scholar
White NJ: Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011, 10: 297-10.1186/1475-2875-10-297.
Article
PubMed Central
PubMed
Google Scholar
Douglas NM, Nosten F, Ashley EA, Phaiphun L, Van Vugt M, Singhasivanon P, White NJ, Price RN: Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis. 2011, 52: 612-620. 10.1093/cid/ciq249.
Article
PubMed Central
PubMed
Google Scholar
Shanks GD, White NJ: The activation of vivax malaria hypnozoites by infectious diseases. Lancet Infect Dis. 2013, 13: 900-906. 10.1016/S1473-3099(13)70095-1.
Article
PubMed
Google Scholar
Lysenko AJ, Semashko IN: Geography of malaria. A medico-geographic profile of an ancient disease. Itogi Nauki: Medicinskaja Geografija. Edited by: Lebedew AW. 1968, Moscow: Academy of Sciences, USSR, 25-146.
Google Scholar
Lover AA, Coker RJ: Quantifying effect of geographic location on epidemiology of Plasmodium vivax malaria. Emerg Infect Dis. 2013, 19: 1058-1065. 10.3201/eid1907.121674.
Article
PubMed Central
PubMed
Google Scholar
Macdonald G: The Epidemiology and Control of Malaria. 1957, London: Oxford University Press
Google Scholar
Holt B, Lessard JP, Borregaard MK, Fritz SA, Araujo MB, Dimitrov D, Fabre PH, Graham CH, Graves GR, Jonsson KA, Nogues-Bravo D, Wang ZH, Whittaker RJ, Fjeldsa J, Rahbek C: An update of Wallace's zoogeographic regions of the world. Science. 2013, 339: 74-78. 10.1126/science.1228282.
Article
CAS
PubMed
Google Scholar
Peel MC, Finlayson BL, McMahon TA: Updated world map of the Koppen-Geiger climate classification. Hydrol Earth Sys Sci. 2007, 11: 1633-1644. 10.5194/hess-11-1633-2007.
Article
Google Scholar
Olson DM, Dinerstein E, Wikramanayake ED, Burgess ND, Powell GVN, Underwood EC, D'Amico JA, Itoua I, Strand HE, Morrison JC, Loucks CJ, Allnutt TF, Ricketts TH, Kura Y, Lamoreux JF, Wettengel WW, Hedao P, Kassem KR: Terrestrial ecoregions of the worlds: a new map of life on Earth. Bioscience. 2001, 51: 933-938. 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2.
Article
Google Scholar
PubMed.http://www.ncbi.nlm.nih.gov/pubmed/,
Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI: G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol. 2013, 81: 133-201.
Article
PubMed
Google Scholar
Cooper WC, Myatt AV, Hernandez T, Jeffery GM, Coatney GR: Studies in human malaria. XXXI. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as curative agents against Chesson strain vivax malaria. Am J Trop Med Hyg. 1953, 2: 949-957.
CAS
PubMed
Google Scholar
Gogtay NJ, Desai S, Kamtekar KD, Kadam VS, Dalvi SS, Kshirsagar NA: Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections. Ann Trop Med Parasitol. 1999, 93: 809-812. 10.1080/00034989957790.
Article
CAS
PubMed
Google Scholar
Alvarez G, Pineros JG, Tobon A, Rios A, Maestre A, Blair S, Carmona-Fonseca J: Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia. Am J Trop Med Hyg. 2006, 75: 605-609.
CAS
PubMed
Google Scholar
Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T: High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet. 1987, 2: 1052-1055.
Article
CAS
PubMed
Google Scholar
Taggart JV, Earle DP, Berliner RW, Welch WJ, Zubrod CG, Jailer JW, Kuhn BH, Norwood J, Shannon JA: Studies on the chemotherapy of the human malarias; the antimalarial activity of quinacrine. J Clin Invest. 1948, 27: 93-97. 10.1172/JCI101979.
Article
PubMed Central
CAS
Google Scholar
Baird JK: Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother. 2004, 48: 4075-4083. 10.1128/AAC.48.11.4075-4083.2004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Guerra CA, Hay SI, Lucioparedes LS, Gikandi PW, Tatem AJ, Noor AM, Snow RW: Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project. Malar J. 2007, 6: 17-10.1186/1475-2875-6-17.
Article
PubMed Central
PubMed
Google Scholar
Google Maps.https://maps.google.com/,
ESRI: ArcGIS Desktop 10.0. 2010, Redlands, CA: Environmental Systems Resource Institute
Google Scholar
Viechtbauer W: Bias and efficiency of meta-analytic variance estimators in the random-effects model. J Educ Behav Stat. 2005, 30: 261-293. 10.3102/10769986030003261.
Article
Google Scholar
Viechtbauer W: Conducting meta-analyses in R with the metafor package. Journal of Statistical Software. 2010, 36: 1-48.
Article
Google Scholar
R Core Team: R: A Language and Environment for Statistical Computing. 2013, Vienna, Austria: R Foundation for Statistical Computing
Google Scholar
Raudenbush SW: Analyzing effect sizes: random effects models. The handbook of research synthesis and meta-analysis. Edited by: Cooper H, Hedges LV, Valentine JC. 2009, New York: Russell Sage Foundation, 295-315. 2
Google Scholar
Freeman MF, Tukey JW: Transformations related to the angular and the square root. Ann Math Stat. 1950, 21: 607-611. 10.1214/aoms/1177729756.
Article
Google Scholar
Clayton D, Hills M: Statistical Models in Epidemiology. 2013, Oxford, UK: Oxford University Press
Google Scholar
Ulm K: A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol. 1990, 131: 373-375.
CAS
PubMed
Google Scholar
Gonzalez-Ceron L, Mu J, Santillan F, Joy D, Sandoval MA, Camas G, Su X, Choy EV, Torreblanca R: Molecular and epidemiological characterization of Plasmodium vivax r ecurrent infections in southern Mexico. Parasit Vectors. 2013, 6: 109-10.1186/1756-3305-6-109.
Article
PubMed Central
PubMed
Google Scholar
Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, Arthur P, Chuenchom N, Mohrle JJ, Duparc S, Ugwuegbulam C, Kleim JP, Carter N, Green JA, Kellam L: Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet. 2014, 383: 1049-1058. 10.1016/S0140-6736(13)62568-4.
Article
CAS
PubMed
Google Scholar
Sharma SN, Subbarao SK, Choudhury DS, Pandey KC: Role of An. culicifacies and An. stephensi in malaria transmission in urban Delhi. Indian J Malariol. 1993, 30: 155-168.
CAS
PubMed
Google Scholar
Sinka ME, Bangs MJ, Manguin S, Chareonviriyaphap T, Patil AP, Temperley WH, Gething PW, Elyazar IR, Kabaria CW, Harbach RE, Hay SI: The dominant Anopheles vectors of human malaria in the Asia-Pacific region: occurrence data, distribution maps and bionomic precis. Parasit Vectors. 2011, 4: 89-10.1186/1756-3305-4-89.
Article
PubMed Central
PubMed
Google Scholar
Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, Fairhurst RM, Herrera S, Kim JY, Menard D, Povoa MM, Villegas L, Mulyanto , Snounou G, Cui L, Zeyrek FY, Escalante AA: The evolutionary history of Plasmodium vivax as inferred from mitochondrial genomes: parasite genetic diversity in the Americas. Mol Biol Evol. 2013, 30: 2050-2064. 10.1093/molbev/mst104.
Article
PubMed Central
CAS
PubMed
Google Scholar
Arnold J, Alving AS, Hockwald RS, Clayman CB, Dern RJ, Beutler E: Natural history of Korean vivax malaria after deliberate inoculation of human volunteers. J Lab Clin Med. 1954, 44: 723-726.
CAS
PubMed
Google Scholar
Cooper WC, Ruhe DS, Coatney CR, Josephson ES, Young MD: Studies in human malaria. VIII. The protective and therapeutic action of quinacrine against St. Elizabeth strain vivax malaria. Am J Hyg. 1949, 49: 25-40.
CAS
PubMed
Google Scholar
Tiburskaja NA, Vrublevskaja OS: The course of infection caused by the North Korean strain of Plasmodium vivax. In WHO Malaria Report 1977. 1977, 895: 1-19. 1–19
Google Scholar
Mueller I, Galinski MR, Tsuboi T, Arevalo-Herrera M, Collins WE, King CL: Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets. Adv Parasitol. 2013, 81: 77-131.
Article
PubMed
Google Scholar
Bignami A: Concerning the pathogenesis of relapses in malarial fevers. South Med J. 1913, 6: 79-89. 10.1097/00007611-191302000-00002.
Article
Google Scholar
Price RN, Douglas NM, Anstey NM: New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis. 2009, 22: 430-435. 10.1097/QCO.0b013e32832f14c1.
Article
PubMed
Google Scholar
Rieckmann KH, Davis DR, Hutton DC: Plasmodium vivax resistance to chloroquine?. Lancet. 1989, 2: 1183-1184.
Article
CAS
PubMed
Google Scholar
Boyd MF: The influence of sporozoite dosage in vivax malaria. Am J Trop M. 1940, 20: 279-286.
Google Scholar
Coatney GR, Cooper WC, YM D, Burgess RW: Studies in human malaria. XVIII. The life pattern of sporozoite-induced St Elizabeth strain vivax malaria. Am J Epidemiol. 1950, 51: 200-215.
Google Scholar
Findlay GM: Recent advances in chemotherapy. 1951, Philadelphia, USA: The Blakiston Company
Google Scholar
Most H: Clinical trials of anti-malarial drugs. Internal Medicine in World War II, Infectious Diseases, vol 2. Volume 2. 1963, Washington, D.C.: Office of the Surgeon General, Department of the Army, 479-492.
Google Scholar
Coatney GR, Alving AS, Jones R, Hankey DD, Robinson DH, Garrison PL, Coker WG, Donovan WN, Di Lorenzo A, Marx RL, Simmons IH: Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am J Trop Med Hyg. 1953, 2: 985-988.
CAS
PubMed
Google Scholar